Altimmune Inc
ALT
NASDAQ
Biotechnology
$2.94
USD
+0.06 (+2.08%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $559.11M
Volume 3.0M
Price Target
$10.00 – $20.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $20.00 and a min estimate of $10.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$15.00
-$1.3 vs prior
Implied Upside
+410.2%
-45.2% vs prior
Analyst Covering
2
-1 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
40%
A mix of recent and older ratings shape this consensus
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Thomas Smith | Leerink Partners | Buy | Initiated | 1 month ago | Plus | Plus | Plus |
Patrick R. Trucchio | HC Wainwright & Co. | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
SGMT
Sagimet Biosciences Inc
$10.55
▲ +13.7%
EIKN
Eikon Therapeutics Inc
$11.05
▲ +7.0%
ARTV
Artiva Biotherapeutics Inc
$11.45
▲ +1.3%
CBIO
Crescent Biopharma Inc
$17.14
▲ +3.1%
PRME
Prime Medicine Inc
$3.09
▼ -2.5%
MDXG
MiMedx Group Inc
$4.27
▲ +1.7%
ZURA
Zura Bio Ltd
$5.57
▼ -1.1%
VSTM
Verastem Inc
$6.58
▼ -1.4%
NVCT
Nuvectis Pharma Inc
$18.96
▼ -1.4%
SPRY
ARS Pharmaceuticals Inc
$5.65
▼ -7.4%